Attenuation of paraquat-induced motor behavior and neurochemical disturbances by L-valine in vivo.

28 Dec 2004
0
0

Attenuation of paraquat-induced motor behavior and neurochemical disturbances by L-valine in vivo.
Chanyachukul T, Yoovathaworn K, Thongsaard W, Chongthammakun S, Navasumrit P, Satayavivad J
Toxicol Lett150p259-69(2004 May 2)

Tags

Share this

Related Posts

A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases
15 Sep 2023
0

A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases

A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases Eurtivong C, Zimmer C, Schirmeister T, Butkinaree C, Saruengkhanphasit R, Niwetmarin W, Ruchirawat S, Bhambra AS Mol Divers. 2023. (In press)
View More
Health Consequences of Environmental Exposures in Early Life: Coping with a Changing World in the Post-MDG Era. Suk, W., Ruchirawat, M., Stein, R. T., Diaz-Barriga, F., Carpenter, D. O., Neira, M., & Sly, P. D. (2016). Annals of Global Health, 82(1), 20-27.
01 Jan 2016
0

Health Consequences of Environmental Exposures in Early Life: Coping with a Changing World in the Post-MDG Era. Suk, W., Ruchirawat, M., Stein, R. T., Diaz-Barriga, F., Carpenter, D. O., Neira, M., & Sly, P. D. (2016). Annals of Global Health, 82(1), 20-27.

Health Consequences of Environmental Exposures in Early Life: Coping with a Changing World in the Post-MDG Era. Suk, W., Ruchirawat, M., Stein, R. T., Diaz-Barriga, F., Carpenter, D. O., Neira, M., & Sly, P. D. (2016). Annals of Global Health, 82(1), 20-27.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More